These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28869943)

  • 1. Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells.
    Venturini E; Leanza L; Azzolini M; Kadow S; Mattarei A; Weller M; Tabatabai G; Edwards MJ; Zoratti M; Paradisi C; Szabò I; Gulbins E; Becker KA
    Neurosignals; 2017; 25(1):26-38. PubMed ID: 28869943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.
    Leanza L; Henry B; Sassi N; Zoratti M; Chandy KG; Gulbins E; Szabò I
    EMBO Mol Med; 2012 Jul; 4(7):577-93. PubMed ID: 22496117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo.
    Leanza L; Romio M; Becker KA; Azzolini M; Trentin L; Managò A; Venturini E; Zaccagnino A; Mattarei A; Carraretto L; Urbani A; Kadow S; Biasutto L; Martini V; Severin F; Peruzzo R; Trimarco V; Egberts JH; Hauser C; Visentin A; Semenzato G; Kalthoff H; Zoratti M; Gulbins E; Paradisi C; Szabo I
    Cancer Cell; 2017 Apr; 31(4):516-531.e10. PubMed ID: 28399409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
    Leanza L; O'Reilly P; Doyle A; Venturini E; Zoratti M; Szegezdi E; Szabo I
    Curr Pharm Des; 2014; 20(2):189-200. PubMed ID: 23701546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.
    Leanza L; Trentin L; Becker KA; Frezzato F; Zoratti M; Semenzato G; Gulbins E; Szabo I
    Leukemia; 2013 Aug; 27(8):1782-5. PubMed ID: 23426166
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of PI-3-K and AKT Amplifies Kv1.3 Inhibitor-Induced Death of Human T Leukemia Cells.
    Bergermann T; Born L; Ferguson F; Latkovic P; Scheul A; Sonnenschein N; Leanza L; Keitsch S; Sehl C; Wilker B; Edwards MJ; Zoratti M; Paradisi C; Kohnen M; Szabo I; Becker KA; Carpinteiro A
    Cell Physiol Biochem; 2019; 53(S1):1-10. PubMed ID: 31804046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions.
    Patel SH; Wilson GC; Wu Y; Keitsch S; Wilker B; Mattarei A; Ahmad SA; Szabo I; Gulbins E
    J Mol Med (Berl); 2024 Jul; 102(7):947-959. PubMed ID: 38780771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzyl isothiocyanate (BITC) induces apoptosis of GBM 8401 human brain glioblastoma multiforms cells via activation of caspase-8/Bid and the reactive oxygen species-dependent mitochondrial pathway.
    Shang HS; Shih YL; Lu TJ; Lee CH; Hsueh SC; Chou YC; Lu HF; Liao NC; Chung JG
    Environ Toxicol; 2016 Dec; 31(12):1751-1760. PubMed ID: 28675694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model.
    Li W; Wilson GC; Bachmann M; Wang J; Mattarei A; Paradisi C; Edwards MJ; Szabo I; Gulbins E; Ahmad SA; Patel SH
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ω3-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: In vitro and in vivo.
    Kim S; Jing K; Shin S; Jeong S; Han SH; Oh H; Yoo YS; Han J; Jeon YJ; Heo JY; Kweon GR; Park SK; Park JI; Wu T; Lim K
    Oncol Rep; 2018 Jan; 39(1):239-246. PubMed ID: 29192322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voltage-Gated Potassium Channels Kv1.3--Potentially New Molecular Target in Cancer Diagnostics and Therapy.
    Teisseyre A; Gąsiorowska J; Michalak K
    Adv Clin Exp Med; 2015; 24(3):517-24. PubMed ID: 26467143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma.
    Zaccagnino A; Managò A; Leanza L; Gontarewitz A; Linder B; Azzolini M; Biasutto L; Zoratti M; Peruzzo R; Legler K; Trauzold A; Kalthoff H; Szabo I
    Oncotarget; 2017 Jun; 8(24):38276-38293. PubMed ID: 27542263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
    Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
    Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes.
    Ren YR; Pan F; Parvez S; Fleig A; Chong CR; Xu J; Dang Y; Zhang J; Jiang H; Penner R; Liu JO
    PLoS One; 2008; 3(12):e4009. PubMed ID: 19104661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides.
    Aissaoui D; Mlayah-Bellalouna S; Jebali J; Abdelkafi-Koubaa Z; Souid S; Moslah W; Othman H; Luis J; ElAyeb M; Marrakchi N; Essafi-Benkhadir K; Srairi-Abid N
    Int J Biol Macromol; 2018 May; 111():1146-1155. PubMed ID: 29415410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.
    Severin F; Urbani A; Varanita T; Bachmann M; Azzolini M; Martini V; Pizzi M; Tos APD; Frezzato F; Mattarei A; Ghia P; Bertilaccio MTS; Gulbins E; Paradisi C; Zoratti M; Semenzato GC; Leanza L; Trentin L; Szabò I
    J Exp Clin Cancer Res; 2022 Feb; 41(1):64. PubMed ID: 35172855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
    Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
    Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family.
    Peruzzo R; Mattarei A; Azzolini M; Becker-Flegler KA; Romio M; Rigoni G; Carrer A; Biasutto L; Parrasia S; Kadow S; Managò A; Urbani A; Rossa A; Semenzato G; Soriano ME; Trentin L; Ahmad S; Edwards M; Gulbins E; Paradisi C; Zoratti M; Leanza L; Szabò I
    Redox Biol; 2020 Oct; 37():101705. PubMed ID: 33007503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels.
    Leanza L; Zoratti M; Gulbins E; Szabò I
    Curr Med Chem; 2012; 19(31):5394-404. PubMed ID: 22856664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo.
    Jang SH; Choi SY; Ryu PD; Lee SY
    Eur J Pharmacol; 2011 Jan; 651(1-3):26-32. PubMed ID: 21087602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.